Literature DB >> 23423441

Antisynthetase antibody syndrome: case report and review of the literature.

Laura Uribe1, Diana Maria Ronderos, Maria Claudia Díaz, Juan Martín Gutierrez, Christina Mallarino, Daniel Gerardo Fernandez-Avila.   

Abstract

Antisynthetase antibody syndrome is a rare autoimmune disease that may present with variable systemic manifestations, mainly polymyositis, interstitial lung disease, skin lesions, and Raynaud's phenomenon. This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease. On the following paper, we report the case of a 52-year-old man who presented with a 2-month history of asymmetric polyarthralgia, myalgia, weight loss of 8 kg, and progressive muscle weakness associated with dyspnea, orthopnea, and dysphonia. Further tests revealed myositis, interstitial pneumonia, and elevation of anti-Jo-1 antibodies. A diagnosis of antisynthetase antibody syndrome was made and the patient showed good response to treatment with corticoids and methotrexate. Finally, we present a short review of the literature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23423441     DOI: 10.1007/s10067-013-2207-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

Review 1.  Update on myositis-specific and myositis-associated autoantibodies.

Authors:  I N Targoff
Journal:  Curr Opin Rheumatol       Date:  2000-11       Impact factor: 5.006

2.  Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome.

Authors:  Baptiste Hervier; Agathe Masseau; Jean-Marie Mussini; Marie Audrain; Mohamed A Hamidou
Journal:  Joint Bone Spine       Date:  2009-05-21       Impact factor: 4.929

3.  Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients.

Authors:  Andrea Váncsa; I Csípo; J Németh; K Dévényi; L Gergely; K Dankó
Journal:  Rheumatol Int       Date:  2009-03-06       Impact factor: 2.631

4.  [Anti-synthetase syndrome].

Authors:  Ane Labirua-Iturburu; Ernesto Trallero Araguás; Albert Selva O'Callaghan
Journal:  Med Clin (Barc)       Date:  2011-05-04       Impact factor: 1.725

5.  Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies.

Authors:  S Sato; M Hirakata; M Kuwana; K Nakamura; A Suwa; S Inada; T Mimori; Y Ikeda
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

6.  Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).

Authors:  I N Targoff; F C Arnett
Journal:  Am J Med       Date:  1990-03       Impact factor: 4.965

7.  Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.

Authors:  Kerry B Stone; Chester V Oddis; Noreen Fertig; Yasuhiro Katsumata; Mary Lucas; Molly Vogt; Robyn Domsic; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2007-09

Review 8.  Spectrum of fibrosing diffuse parenchymal lung disease.

Authors:  Adam S Morgenthau; Maria L Padilla
Journal:  Mt Sinai J Med       Date:  2009-02

9.  Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus.

Authors:  S Guglielmi; T M Merz; M Gugger; C Suter; L P Nicod
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

Review 10.  Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome.

Authors:  Magdalena Jankowska; Barbara Butto; Alicja Debska-Slizień; Bolesław Rutkowski
Journal:  Rheumatol Int       Date:  2007-01-13       Impact factor: 3.580

View more
  5 in total

1.  Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.

Authors:  Kishore Malyavantham; Bianca Weinstock-Guttman; Lakshmanan Suresh; Robert Zivadinov; Thomas Shanahan; Darlene Badgett; Murali Ramanathan
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

Review 2.  Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies.

Authors:  Boel De Paepe; Jana Zschüntzsch
Journal:  Int J Mol Sci       Date:  2015-08-11       Impact factor: 5.923

Review 3.  Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.

Authors:  Hidenaga Kawasumi; Takahisa Gono; Yasushi Kawaguchi; Hisashi Yamanaka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-07-23

4.  Anti-Ro52-positive antisynthetase syndrome (ASS): a case report and review of the literature.

Authors:  Yuqing Zhu; Bin Tang; Mande Kang; Qifan Xiao
Journal:  Ann Transl Med       Date:  2022-03

5.  Anti-synthetase syndrome presenting with interstitial lung disease.

Authors:  Panagiotis Athanassiou; Markos Kostopoulos; Aikaterini Tzanavari; Anestis Spyridis; Ifigenia Kostoglou-Athanassiou
Journal:  Mediterr J Rheumatol       Date:  2017-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.